Expertise in
19
conditions

Dr. Douglas Ciuba

Radiation Oncology
Regional Oncology LLC
1831 5th Ave, 
Columbus, GA 
Offers Telehealth
Expertise in
19
conditions
Regional Oncology LLC
1831 5th Ave, 
Columbus, GA 

Overview

Douglas Ciuba is a Radiation Oncologist in Columbus, Georgia. Dr. Ciuba is highly rated in 19 conditions, according to our data. His top areas of expertise are Adenoid Cystic Carcinoma, Lung Cancer, Pleuropulmonary Blastoma, and Familial Prostate Cancer.

His clinical research consists of co-authoring 2 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Radiation Oncology

Licenses

Radiology in GA

Hospital Affiliations

St Francis Hospital- Emory Healthcare
Piedmont Columbus Regional Midtown
Piedmont Columbus Regional Northside

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Regional Oncology LLC
1831 5th Ave, Columbus, GA 31904

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Enrollment Status: Active_not_recruiting
Publish Date: October 28, 2025
Intervention Type: Radiation
Study Phase: Phase 3
GRECO-1: Phase I/II, Randomized, Placebo-Controlled Study of Stereotactic Body Radiation Therapy (SBRT) and GC4711 for Centrally Located or Large, Node-Negative Non-Small Cell Lung Cancer (NSCLC)
GRECO-1: Phase I/II, Randomized, Placebo-Controlled Study of Stereotactic Body Radiation Therapy (SBRT) and GC4711 for Centrally Located or Large, Node-Negative Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Terminated
Publish Date: April 30, 2024
Intervention Type: Drug
Study Drug: GC4711
Study Phase: Phase 1/Phase 2
ROMAN: Reduction in Oral Mucositis With Avasopasem Manganese (GC4419) - Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer
ROMAN: Reduction in Oral Mucositis With Avasopasem Manganese (GC4419) - Phase 3 Trial in Patients Receiving Chemoradiotherapy for Locally-Advanced, Non-Metastatic Head and Neck Cancer
Enrollment Status: Completed
Publish Date: October 24, 2023
Intervention Type: Drug
Study Drug: GC4419
Study Phase: Phase 3
A Phase 2b/3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Comparing the Efficacy and Safety of Clonidine Mucoadhesive Buccal Tablet to Placebo to Prevent Chemoradiotherapy-induced Severe Oral Mucositis in Patients With Oropharyngeal Cancer
A Phase 2b/3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Comparing the Efficacy and Safety of Clonidine Mucoadhesive Buccal Tablet to Placebo to Prevent Chemoradiotherapy-induced Severe Oral Mucositis in Patients With Oropharyngeal Cancer
Enrollment Status: Terminated
Publish Date: May 31, 2023
Intervention Type: Drug
Study Drug: Clonidine HCl Mucoadhesive Buccal Tablet
Study Phase: Phase 2/Phase 3
A Phase 2a Open-Label Trial of the Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis in Subjects Receiving Chemoradiotherapy for Lung Cancer
A Phase 2a Open-Label Trial of the Effects of Intravenous GC4419 on the Incidence and Severity of Esophagitis in Subjects Receiving Chemoradiotherapy for Lung Cancer
Enrollment Status: Terminated
Publish Date: March 23, 2023
Intervention Type: Drug
Study Drug: GC4419
Study Phase: Phase 2
Open-label, Randomized, Controlled, Phase 3 Safety and Efficacy Study of Trans Sodium Crocetinate With Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects
Open-label, Randomized, Controlled, Phase 3 Safety and Efficacy Study of Trans Sodium Crocetinate With Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects
Enrollment Status: Terminated
Publish Date: July 22, 2021
Intervention Type: Drug, Other
Study Phase: Phase 3
View 5 Less Clinical Trials

2 Total Publications

Avasopasem manganese treatment for severe oral mucositis from chemoradiotherapy for locally advanced head and neck cancer: phase 3 randomized controlled trial (ROMAN).
Avasopasem manganese treatment for severe oral mucositis from chemoradiotherapy for locally advanced head and neck cancer: phase 3 randomized controlled trial (ROMAN).
Journal: EClinicalMedicine
Published: December 29, 2024
Similar Doctors
Expertise in
23
conditions
Dr. Woodrow Mcwilliams
Radiation Oncology
Expertise in
23
conditions
Dr. Woodrow Mcwilliams
Radiation Oncology

Regional Oncology LLC

1831 5th Ave, 
Columbus, GA 
 (0.1 miles away)
706-571-1050
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Woodrow Mcwilliams is a Radiation Oncologist in Columbus, Georgia. Dr. Mcwilliams is highly rated in 23 conditions, according to our data. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Laryngeal Cancer, and Pleuropulmonary Blastoma.

Expertise in
10
conditions
Dr. John Cabelka
Radiation Oncology
Expertise in
10
conditions
Dr. John Cabelka
Radiation Oncology

Spencer Cancer Center

2501 Village Professional Dr, 
Opelika, AL 
 (27.3 miles away)
334-528-1070
Languages Spoken:
English
See accepted insurances

John Cabelka is a Radiation Oncologist in Opelika, Alabama. Dr. Cabelka is highly rated in 10 conditions, according to our data. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Pleuropulmonary Blastoma, and Breast Cancer.

Expertise in
2
conditions
Dr. Eugene Fortune
Radiation Oncology
Expertise in
2
conditions
Dr. Eugene Fortune
Radiation Oncology

Regional Oncology LLC

1831 5th Ave, 
Columbus, GA 
 (0.1 miles away)
706-571-1050
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Eugene Fortune is a Radiation Oncologist in Columbus, Georgia. Dr. Fortune is highly rated in 2 conditions, according to our data. His top areas of expertise are Throat Cancer, Laryngeal Cancer, Familial Prostate Cancer, and Prostate Cancer.

Frequently Asked Questions about Dr. Douglas Ciuba

How do I make an appointment with Dr. Douglas Ciuba?

You can book an appointment with Dr. Douglas Ciuba by calling their office at 706-321-6600. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Douglas Ciuba a top-rated expert for Adenoid Cystic Carcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Douglas Ciuba is classified as an Distinguished expert for Adenoid Cystic Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Douglas Ciuba specialize in?

While Dr. Douglas Ciuba is a Radiation Oncology, they have specific expertise in Adenoid Cystic Carcinoma, Lung Cancer, and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Douglas Ciuba participate in research or clinical trials?

Yes. Dr. Douglas Ciuba has published 2 articles and abstracts on conditions like Adenoid Cystic Carcinoma. You can view a list of Dr. Douglas Ciuba's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Douglas Ciuba accept my insurance?

Dr. Douglas Ciuba accepts most major insurance plans, including Aetna and Alliant Health. We recommend calling the office directly at 706-321-6600 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ciuba's expertise for a condition
ConditionClose
    View All 13 Advanced Conditions
    View All 71 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile